These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 16212141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives.
    van Ahlen H, Wahle K, Kupper W, Yassin A, Reblin T, Neureither M.
    J Sex Med; 2005 Nov; 2(6):856-64. PubMed ID: 16422810
    [Abstract] [Full Text] [Related]

  • 4. The efficacy and safety of vardenafil in East Asian men with erectile dysfunction.
    Chen KK, Paick JS, Ishii N, On Behalf Of The Vardenafil Study Group.
    J Sex Med; 2007 May; 4(3):753-761. PubMed ID: 17498108
    [Abstract] [Full Text] [Related]

  • 5. Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study.
    Rosenberg MT, Adams PL, McBride TA, Roberts JN, McCallum SW.
    Int J Clin Pract; 2009 Jan; 63(1):27-34. PubMed ID: 19125990
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Duration of erection: does it really matter? A randomized, double-blind clinical trial to assess the impact of vardenafil ODT on duration of erection and its correlation with patients' and partners' sexual quality of life and duration of intercourse: the VADEOPEN study.
    Martin-Morales A, Gutiérrez-Hernández P, Romero-Otero J, Romero-Martín JA, Vadeopen Study Group.
    J Sex Med; 2014 Jun; 11(6):1527-38. PubMed ID: 24628736
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial.
    Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, Padma-Nathan H, Vardenafil Study Group.
    Urology; 2003 Apr; 61(4 Suppl 1):8-14. PubMed ID: 12657355
    [Abstract] [Full Text] [Related]

  • 12. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
    Nehra A, Grantmyre J, Nadel A, Thibonnier M, Brock G.
    J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of vardenafil in Asian men with erectile dysfunction.
    Tan HM, Chin CM, Chua CB, Gatchalian E, Kongkanand A, Moh CL, Ng FC, Ratana-Olarn K, Serrano D, Taher A, Tambi I, Tantiwong A, Chen MW, Yip WC.
    Asian J Androl; 2008 May; 10(3):495-502. PubMed ID: 18385912
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy and safety of oral vardenafil in the treatment of erectile dysfunction].
    Pan T, Zhuang S, Ma H, Hong K, Tang W.
    Zhonghua Nan Ke Xue; 2004 Dec; 10(12):955-9. PubMed ID: 15638033
    [Abstract] [Full Text] [Related]

  • 15. The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.
    Sperling H, Debruyne F, Boermans A, Beneke M, Ulbrich E, Ewald S.
    J Sex Med; 2010 Apr; 7(4 Pt 1):1497-507. PubMed ID: 20233275
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of vardenafil for the treatment of erectile dysfunction in men with metabolic syndrome: results of a randomized, placebo-controlled trial.
    Schneider T, Gleissner J, Merfort F, Hermanns M, Beneke M, Ulbrich E.
    J Sex Med; 2011 Oct; 8(10):2904-11. PubMed ID: 21771281
    [Abstract] [Full Text] [Related]

  • 17. The effect of physician and patient education when combined with vardenafil treatment in Canadian males with erectile dysfunction: an open-label, factorial-designed, cluster-randomized clinical trial.
    Brock G, Carrier S, Alarie P, Pommerville P, Casey R, Harris S, Ward R.
    J Sex Med; 2008 Mar; 5(3):705-15. PubMed ID: 18304285
    [Abstract] [Full Text] [Related]

  • 18. Vardenafil provides reliable efficacy over time in men with erectile dysfunction.
    Montorsi F, Hellstrom WJ, Valiquette L, Bastuba M, Collins O, Taylor T, Thibonnier M, Homering M, Eardley I, North American and European Vardenafil Groups.
    Urology; 2004 Dec; 64(6):1187-95. PubMed ID: 15596195
    [Abstract] [Full Text] [Related]

  • 19. Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study.
    Rubio-Aurioles E, Porst H, Eardley I, Goldstein I.
    J Sex Med; 2006 Nov; 3(6):1037-1049. PubMed ID: 17100937
    [Abstract] [Full Text] [Related]

  • 20. Vardenafil: a review of its use in erectile dysfunction.
    Keating GM, Scott LJ.
    Drugs; 2003 Nov; 63(23):2673-703. PubMed ID: 14636086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.